BDTX Black Diamond Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$1,89
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,6052 haftanın en düşüğü
$4,9452 haftanın en yükseği
Piyasa Değeri (MRQ)
$109M
P/E (TTM)
-2.6
Hisse Başına Kâr (TTM)
$-0.73
Gelir (TTM)
$0
rozetleriniz
52 Haftlık Aralık
$2–$5
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$10
P/E
-2.6
ROE
-37.2%
Net Kâr Marjı
31.9%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
BDTX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.89
Piyasa Değeri (MRQ)
$109M
P/E (TTM)
-2.6
Hisse Başına Kâr (TTM)
$-0.73
Gelir (TTM)
$0
ROE (TTM)
-37.2%
52 Haftlık Aralık
$2–$5
BDTX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$70M2018-12-31 → 2025-12-31
Hisse Başına Kâr$0.392020-12-31 → 2025-12-31
Serbest Nakit Akışı·2019-12-31 → 2024-12-31
Net kar marjı31.9%2025-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | BDTX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -2.65Y ort. ≈0.2 | ≈0.2 | · | · | |
| P/S (F/S) | 1.5 | · | 17.2 | Düşük değerli | |
| F/D (MRQ) | 1.15Y ort. ≈1.1 | ≈1.1 | 1.7 | Düşük değerli | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | 3.75Y ort. ≈-0.4 | ≈-0.4 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.05Y ort. ≈1.1 | ≈1.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | BDTX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Operating Margin (Faaliyet Kâr Marjı) | 17.9% | · | -1088.2% | En üst düzey | |
| EBITDA Margin (FAVÖK Marjı) | 17.9% | · | -1088.2% | En üst düzey | |
| Net Profit Margin (Net Kâr Marjı) | 31.9% | · | -988.2% | En üst düzey | |
| ROA (TTM) | -29.2%5Y ort. ≈-34.7% | ≈-34.7% | -50.5% | En üst düzey | |
| ROE (TTM) | -37.2%5Y ort. ≈-51.7% | ≈-51.7% | -88.6% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | BDTX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 7.35Y ort. ≈7.5 | ≈7.5 | 7.5 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 1.35Y ort. ≈2.2 | ≈2.2 | 4.9 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | BDTX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.5 | · | 0.0 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$3.3M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
639.8%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 6, 2026 | $-0.17 | $-0.20 | 14.7% |
| 31 Mart 2026 | May 13, 2026 | $-0.16 | $-0.19 | 15.1% |
| 31 Aralık 2025 | $-0.27 | $-0.19 | -42.1% | |
| 30 Eylül 2025 | $-0.15 | $-0.24 | 37.3% | |
| 30 Haziran 2025 | $-0.19 | $-0.25 | 24.5% | |
| 31 Mart 2025 | $0.98 | $0.02 | 4416.1% | |
| 31 Aralık 2024 | $-0.28 | $-0.32 | 12.8% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $0 | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $34M | $51M | $59M | $64M | $97M | $48M | $22M | $7M | |
| SG&A Expense | $17M | $27M | $27M | $28M | $30M | $21M | $8M | $2M | |
| Operating Expenses | $57M | $79M | $86M | $93M | $127M | $70M | $29M | $9M | |
| Operating Income | $13M | $-79M | $-86M | $-93M | $-127M | $-70M | $-29M | $-9M | |
| Interest Expense | · | · | · | · | $0 | $1.0K | $0 | · | |
| Other Non-op | $6M | $7M | $2M | $-354.0K | $-2M | $-2M | $6.0K | $-16.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $22M | $-70M | $-82M | $-91M | $-126M | $-67M | $-35M | $-9M | |
| EPS (Basic) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · | |
| EPS (Diluted) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · | |
| Shares (Basic) | 56,868,111 | 55,028,371 | 43,954,649 | 36,325,586 | 36,189,002 | 32,907,100 | · | · | |
| Shares (Diluted) | 57,562,746 | 55,028,371 | 43,954,649 | 36,325,586 | 36,189,002 | 32,907,100 | · | · | |
| EBITDA | $13M | $-79M | $-86M | $-93M | $-127M | $-70M | $-29M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $36M | $56M | $34M | $66M | $35M | $155M | $52M | |
| Prepaid Expense | $4M | $3M | $3M | $5M | $6M | $4M | $1M | $24.0K | |
| Current Assets | $132M | $101M | $134M | $128M | $216M | $320M | $156M | $52M | |
| PP&E (Net) | $365.0K | $1M | $2M | $3M | $3M | $385.0K | $164.0K | $134.0K | |
| PP&E (Gross) | $2M | $3M | $3M | $3M | $3M | $549.0K | $276.0K | $234.0K | |
| Accum. Depreciation | $1M | $1M | $799.0K | $750.0K | $369.0K | $164.0K | $112.0K | $100.0K | |
| Other Non-current Assets | $73.0K | $249.0K | $0 | $0 | $16.0K | $106.0K | $59.0K | $8.0K | |
| Total Assets | $143M | $123M | $159M | $156M | $248M | $330M | $158M | $52M | |
| Accounts Payable | $579.0K | $4M | $2M | $2M | $4M | $3M | $2M | $416.0K | |
| Accrued Liabilities | $15M | $17M | $17M | $13M | $20M | $12M | $3M | $452.0K | |
| Current Liabilities | $16M | $21M | $20M | $15M | $24M | $14M | $5M | $3M | |
| Capital Leases | $15M | $19M | $22M | $25M | $28M | $8M | · | · | |
| Total Liabilities | $31M | $39M | $42M | $41M | $52M | $22M | $5M | $7M | |
| Common Stock | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $1.0K | $1.0K | |
| Paid-in Capital | $577M | $570M | $534M | $453M | $440M | $425M | $4M | $169.0K | |
| Retained Earnings | $-465M | $-487M | $-417M | $-335M | $-244M | $-118M | $-51M | $-16M | |
| AOCI | $101.0K | $24.0K | $-27.0K | $-2M | $-414.0K | $614.0K | $0 | · | |
| Stockholders' Equity | $112M | $83M | $117M | $116M | $196M | $308M | $-47M | $-16M | |
| Liabilities + Equity | $143M | $123M | $159M | $156M | $248M | $330M | $158M | $52M | |
| Shares Outstanding | 57,138,057 | 56,644,655 | 51,645,557 | 36,434,297 | 36,234,624 | 36,078,383 | 2,236,672 | 2,173,684 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $11M | $10M | $12M | $14M | $8M | $4M | $64.0K | |
| Restructuring | · | $3M | · | · | · | · | · | · | |
| Operating Cash Flow | $30M | $-62M | $-67M | $-85M | $-100M | $-52M | $-25M | $-8M | |
| CapEx | · | $0 | $33.0K | $192.0K | $3M | $142.0K | $21.0K | $76.0K | |
| Investing Cash Flow | $-45M | $17M | $16M | $53M | $131M | $-282M | $-21.0K | $-76.0K | |
| Stock Issued | $0 | $24M | $72M | $0 | · | · | · | · | |
| Net Stock Activity | $0 | $24M | $72M | · | · | · | · | · | |
| Financing Cash Flow | $-146.0K | $26M | $72M | $177.0K | $729.0K | $215M | $128M | $52M | |
| Net Change in Cash | $-15M | $-20M | $22M | $-32M | $31M | $-119M | $103M | $44M | |
| Free Cash Flow | · | $-62M | $-67M | $-85M | $-103M | $-52M | $-25M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.9% | · | · | · | · | · | · | · | |
| Net Margin | 31.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | 17.9% | · | · | · | · | · | · | · | |
| ROA | 16.8% | -49.5% | -52.4% | -45.1% | -43.5% | -27.6% | -33.6% | · | |
| ROE | 18.3% | -77.1% | -65.7% | -73.2% | -60.6% | -21.2% | 81.1% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 4.9 | 6.8 | 8.4 | 9.1 | 22.5 | 32.0 | · | |
| Quick Ratio | 1.3 | 1.8 | 2.9 | 2.2 | 2.8 | 2.4 | 31.8 | · | |
| Interest Coverage | · | · | · | · | · | -69570.0 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | · | · | · | 0.0 | 0.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.96 | $1.47 | $2.26 | $3.18 | $5.41 | $8.53 | $-21.08 | · | |
| Revenue / Share | $1.22 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.51 | $-1.13 | $-1.52 | $-2.34 | $-2.77 | · | · | · | |
| Cash / Share | $0.37 | $0.64 | $1.09 | $0.94 | $1.82 | $0.96 | $69.15 | · | |
| EPS (TTM) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $22M | $-70M | $-82M | $-91M | $-126M | $-67M | $-35M | · | |
| Market Cap | $139M | $121M | $145M | $66M | $193M | $1.16B | · | · | |
| P/E | 6.2 | -1.7 | -1.5 | -0.7 | -1.5 | -15.6 | · | · | |
| P/S | 2.0 | · | · | · | · | · | · | · | |
| P/B | 1.2 | 1.5 | 1.2 | 0.6 | 1.0 | 3.8 | · | · | |
| P / Tangible Book | 1.2 | 1.5 | 1.2 | 0.6 | 1.0 | 3.8 | · | · | |
| P / Cash Flow | 4.7 | -1.9 | -2.2 | -0.8 | -1.9 | -22.2 | · | · | |
| P / FCF | · | -1.9 | -2.2 | -0.8 | -1.9 | -22.1 | · | · | |
| Earnings Yield | 16.1% | -59.4% | -66.9% | -140.0% | -65.1% | -6.4% | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $70M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| R&D Expense | $7M | $7M | $6M | $7M | $9M | $11M | $12M | $13M | $13M | $14M | $15M | $16M | $13M | $15M | $15M | $16M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $5M | $6M | $5M | $10M | $7M | $6M | $8M | $7M | $7M | $7M | $6M | |
| Operating Expenses | $12M | $11M | $18M | $11M | $13M | $15M | $18M | $18M | $22M | $20M | $21M | $24M | $20M | $22M | $22M | $22M | |
| Operating Income | $-12M | $-11M | $-18M | $-11M | $-13M | $55M | $-18M | $-18M | $-22M | $-20M | $-21M | $-24M | $-20M | $-22M | $-22M | $-22M | |
| Other Non-op | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $566.0K | $341.0K | $64.0K | $115.0K | $-92.0K | |
| Income Tax | · | · | · | · | $0 | $226.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-10M | $-9M | $-15M | $-8M | $-11M | $57M | $-16M | $-16M | $-20M | $-18M | $-19M | $-23M | $-19M | $-21M | $-21M | $-22M | |
| EPS (Basic) | $-0.17 | $-0.16 | $-0.27 | $-0.15 | $-0.19 | $1.00 | $-0.28 | $-0.28 | $-0.36 | $-0.35 | $-0.34 | $-0.45 | $-0.52 | $-0.57 | $-0.59 | $-0.60 | |
| EPS (Diluted) | $-0.17 | $-0.16 | $-0.25 | $-0.15 | $-0.19 | $0.98 | $-0.28 | $-0.28 | $-0.36 | $-0.35 | $-0.34 | $-0.45 | $-0.52 | $-0.57 | $-0.59 | $-0.60 | |
| Shares (Basic) | 57,367,283 | 57,233,413 | · | 56,929,103 | 56,803,450 | 56,663,798 | · | 56,507,956 | 55,155,220 | 51,808,849 | · | 50,943,155 | 36,516,114 | 36,483,878 | · | 36,346,181 | |
| Shares (Diluted) | 57,367,283 | 57,233,413 | · | 56,929,103 | 56,803,450 | 57,673,099 | · | 56,507,956 | 55,155,220 | 51,808,849 | · | 50,943,155 | 36,516,114 | 36,483,878 | · | 36,346,181 | |
| EBITDA | $-12M | $-11M | · | $-11M | $-13M | $55M | · | $-18M | $-22M | $-20M | · | $-24M | $-20M | $-22M | · | $-22M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $30M | $21M | $31M | $30M | $98M | $36M | $23M | $33M | $25M | $56M | $58M | $42M | $39M | $34M | $54M | |
| Prepaid Expense | $5M | $5M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $5M | $5M | $7M | |
| Current Assets | $115M | $123M | $132M | $139M | $147M | $156M | $101M | $116M | $127M | $119M | $134M | $147M | $93M | $108M | $128M | $151M | |
| PP&E (Net) | $310.0K | $338.0K | $365.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| PP&E (Gross) | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $971.0K | $885.0K | $799.0K | $738.0K | $959.0K | $845.0K | $750.0K | $710.0K | |
| Other Non-current Assets | $285.0K | $29.0K | $73.0K | $117.0K | $161.0K | $205.0K | $249.0K | $293.0K | $337.0K | · | $0 | · | · | · | · | $0 | |
| Total Assets | $125M | $133M | $143M | $158M | $166M | $176M | $123M | $138M | $150M | $143M | $159M | $172M | $120M | $136M | $156M | $180M | |
| Accounts Payable | $1M | $3M | $579.0K | $975.0K | $771.0K | $3M | $4M | $2M | $763.0K | $1M | $2M | $694.0K | $3M | $3M | $2M | $6M | |
| Accrued Liabilities | $14M | $12M | $15M | $15M | $16M | $14M | $17M | $19M | $18M | $16M | $17M | $14M | $11M | $10M | $13M | $15M | |
| Current Liabilities | $16M | $15M | $16M | $16M | $17M | $17M | $21M | $21M | $18M | $17M | $20M | $15M | $14M | $13M | $15M | $21M | |
| Capital Leases | $13M | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $21M | $21M | $22M | $23M | $24M | $25M | $25M | $26M | |
| Total Liabilities | $29M | $29M | $31M | $32M | $34M | $35M | $39M | $40M | $39M | $38M | $42M | $38M | $38M | $37M | $41M | $47M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $580M | $578M | $577M | $576M | $574M | $572M | $570M | $568M | $567M | $540M | $534M | $533M | $458M | $455M | $453M | $450M | |
| Retained Earnings | $-484M | $-474M | $-465M | $-450M | $-441M | $-431M | $-487M | $-471M | $-456M | $-436M | $-417M | $-398M | $-375M | $-356M | $-335M | $-314M | |
| AOCI | $-68.0K | $-36.0K | $101.0K | $142.0K | $-25.0K | $-19.0K | $24.0K | $107.0K | $-115.0K | $-95.0K | $-27.0K | $-364.0K | $-661.0K | $-1M | $-2M | $-2M | |
| Stockholders' Equity | $96M | $104M | $112M | $126M | $133M | $142M | $83M | $97M | $111M | $104M | $117M | $134M | $82M | $98M | $116M | $133M | |
| Liabilities + Equity | $125M | $133M | $143M | $158M | $166M | $176M | $123M | $138M | $150M | $143M | $159M | $172M | $120M | $136M | $156M | $180M | |
| Shares Outstanding | 57,446,349 | 57,301,774 | 57,138,057 | 56,943,413 | 56,886,939 | 56,676,716 | 56,644,655 | 56,521,914 | 56,408,487 | 52,527,626 | 51,645,557 | 51,635,184 | 36,533,525 | 36,511,947 | 36,434,297 | 36,366,206 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-8M | $-10M | $-7M | $-8M | $-9M | $53M | $-15M | $-11M | $-15M | $-21M | $-14M | $-18M | $-14M | $-20M | $-22M | $-16M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $33.0K | $0 | $0 | $0 | $-8.0K | |
| Investing Cash Flow | $-3M | $20M | $-3M | $9M | $-59M | $9M | $28M | $2M | $740.0K | $-14M | $12M | $-38M | $17M | $25M | $2M | $15M | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $-500.0K | $21M | $4M | $0 | $72M | $0 | $0 | $0 | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $4M | · | · | · | · | · | · | |
| Financing Cash Flow | $217.0K | $-185.0K | $-196.0K | $134.0K | $-116.0K | $32.0K | $291.0K | $-252.0K | $21M | $4M | $-46.0K | $72M | $0 | $51.0K | $-28.0K | $52.0K | |
| Net Change in Cash | $-11M | $9M | $-10M | $874.0K | $-68M | $62M | $13M | $-9M | $7M | $-31M | $-2M | $16M | $3M | $5M | $-20M | $-2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-20M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | 77.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | · | · | 80.8% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | 77.9% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -6.8% | -5.9% | · | -5.8% | -6.7% | 35.5% | · | -10.0% | -14.8% | -13.1% | · | -13.0% | -12.0% | -11.8% | · | -9.5% | |
| ROE | -8.7% | -7.3% | · | -7.6% | -8.7% | 46.0% | · | -13.4% | -20.6% | -18.0% | · | -17.2% | -16.3% | -15.4% | · | -12.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | 8.5 | · | 8.9 | 8.7 | 9.2 | · | 5.6 | 6.9 | 7.0 | · | 9.8 | 6.7 | 8.4 | · | 7.1 | |
| Quick Ratio | 1.2 | 2.1 | · | 2.0 | 1.8 | 5.8 | · | 1.1 | 1.8 | 1.5 | · | 3.8 | 3.0 | 3.0 | · | 2.6 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.4 | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.67 | $1.82 | · | $2.22 | $2.33 | $2.50 | · | $1.72 | $1.97 | $1.99 | · | $2.60 | $2.25 | $2.69 | · | $3.66 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $1.21 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $0.93 | · | · | · | $-0.41 | · | · | · | $-0.55 | · | · | |
| Cash / Share | $0.33 | $0.52 | · | $0.54 | $0.53 | $1.74 | · | $0.41 | $0.58 | $0.48 | · | $1.12 | $1.15 | $1.07 | · | $1.48 | |
| EPS (TTM) | $-0.73 | $-0.75 | · | $0.36 | $0.23 | $0.06 | · | $-1.33 | $-1.50 | $-1.66 | · | $-2.13 | $-2.28 | $-2.39 | · | $-2.64 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $70M | $70M | $70M | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-43M | $-43M | · | $21M | $14M | $5M | · | $-73M | $-81M | $-80M | · | $-84M | $-83M | $-87M | · | $-96M | |
| Market Cap | $106M | $122M | · | $216M | $141M | $88M | · | $246M | $263M | $266M | · | $148M | $184M | $69M | · | $61M | |
| P/E | -2.5 | -2.8 | · | 10.5 | 10.8 | 25.8 | · | -3.3 | -3.1 | -3.1 | · | -1.3 | -2.2 | -0.8 | · | -0.6 | |
| P/S | · | · | · | 3.1 | 2.0 | 1.3 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.1 | 1.2 | · | 1.7 | 1.1 | 0.6 | · | 2.5 | 2.4 | 2.6 | · | 1.1 | 2.2 | 0.7 | · | 0.5 | |
| P / Tangible Book | 1.1 | 1.2 | · | 1.7 | 1.1 | 0.6 | · | 2.5 | 2.4 | 2.6 | · | 1.1 | 2.2 | 0.7 | · | 0.5 | |
| P / Cash Flow | · | -11.9 | · | · | · | 1.6 | · | · | · | -12.6 | · | · | · | -3.4 | · | · | |
| Earnings Yield | -39.5% | -35.2% | · | 9.5% | 9.3% | 3.9% | · | -30.6% | -32.2% | -32.7% | · | -74.2% | -45.1% | -126.5% | · | -156.2% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $70M | $0 | · | · | · |
| Faaliyet Kâr Marjı % | 17.9% | · | · | · | · |
| Net Gelir | $22M | $-70M | $-82M | $-91M | $-126M |
| Seyreltilmiş Hisse Başı Kâr | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 8.4 | 4.9 | 6.8 | 8.4 | 9.1 |
| Cari Oran | 1.3 | 1.8 | 2.9 | 2.2 | 2.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | $-62M | $-67M | $-85M | $-103M |
Kurumsal Sahipler (13F) 108 dosya · $58.9M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
108
Tutulan Değer
$58.9M
Yeni pozisyonlar
27
Çıkan pozisyonlar
30
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 27 (+4 önceki Ç'ye göre) | 30 (+11 önceki Ç'ye göre) | 37 (+3 önceki Ç'ye göre) | 26 (-7 önceki Ç'ye göre) | -3.0M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| NEA Management Company, LLC | $8.230.200 | 4.448.757 | 13,97% | Hisse senetleri |
| BlackRock, Inc. | $7.246.613 | 3.917.088 | 12,30% | Hisse senetleri |
| VANGUARD GROUP INC | $5.318.922 | 2.188.857 | 9,03% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.931.750 | 2.125.270 | 6,67% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $3.630.429 | 1.962.394 | 6,16% | Hisse senetleri |
| Defilade Capital Management, L.P. | $3.098.748 | 1.674.999 | 5,26% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $2.525.486 | 1.365.384 | 4,29% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $2.254.419 | 1.218.171 | 3,83% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $2.021.837 | 1.092.885 | 3,43% | Hisse senetleri |
| AWM Investment Company, Inc. | $1.850.000 | 1.000.000 | 3,14% | Hisse senetleri |
| MARSHALL WACE, LLP | $1.658.714 | 896.602 | 2,81% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1.464.153 | 791.434 | 2,48% | Hisse senetleri |
| FMR LLC | $1.190.786 | 643.668 | 2,02% | Hisse senetleri |
| Balyasny Asset Management L.P. | $1.003.018 | 542.172 | 1,70% | Hisse senetleri |
| STATE STREET CORP | $971.274 | 525.013 | 1,65% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $765.004 | 413.516 | 1,30% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $753.087 | 407.074 | 1,28% | Hisse senetleri |
| NORTHERN TRUST CORP | $675.979 | 365.394 | 1,15% | Hisse senetleri |
| Bank of New York Mellon Corp | $589.713 | 318.763 | 1,00% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $573.228 | 309.853 | 0,97% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $546.068 | 295.172 | 0,93% | Hisse senetleri |
| JANE STREET GROUP, LLC | $535.967 | 289.712 | 0,91% | Hisse senetleri |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $534.411 | 288.871 | 0,91% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $534.243 | 288.780 | 0,91% | Hisse senetleri |
| STIFEL FINANCIAL CORP | $520.304 | 281.245 | 0,88% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $491.290 | 265.562 | 0,83% | Hisse senetleri |
| UBS Group AG | $490.830 | 265.313 | 0,83% | Hisse senetleri |
| Empowered Funds, LLC | $459.048 | 248.134 | 0,78% | Hisse senetleri |
| MORGAN STANLEY | $427.720 | 231.200 | 0,73% | Hisse senetleri |
| TORONTO DOMINION BANK | $395.900 | 214.000 | 0,67% | Alım opsiyonu |
| RITHOLTZ WEALTH MANAGEMENT | $330.186 | 178.479 | 0,56% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $291.079 | 157.340 | 0,49% | Hisse senetleri |
| Invesco Ltd. | $243.577 | 131.663 | 0,41% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $199.223 | 107.688 | 0,34% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $191.660 | 103.600 | 0,33% | Hisse senetleri |
| RB Capital Management, LLC | $185.000 | 100.000 | 0,31% | Hisse senetleri |
| CITADEL ADVISORS LLC | $166.500 | 90.000 | 0,28% | Alım opsiyonu |
| AMERICAN CENTURY COMPANIES INC | $150.425 | 81.311 | 0,26% | Hisse senetleri |
| Quadrature Capital Ltd | $141.906 | 76.706 | 0,24% | Hisse senetleri |
| Nuveen, LLC | $119.882 | 64.801 | 0,20% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $115.135 | 62.235 | 0,20% | Hisse senetleri |
| CITADEL ADVISORS LLC | $112.850 | 61.000 | 0,19% | Satım opsiyonu |
| Graham Capital Management, L.P. | $100.329 | 54.232 | 0,17% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $97.865 | 52.900 | 0,17% | Alım opsiyonu |
| DEUTSCHE BANK AG\ | $85.170 | 46.038 | 0,14% | Hisse senetleri |
| XTX Topco Ltd | $81.957 | 44.301 | 0,14% | Hisse senetleri |
| Point72 Asia (Singapore) Pte. Ltd. | $78.121 | 20.613 | 0,13% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $77.700 | 42.000 | 0,13% | Hisse senetleri |
| DLK Investment Management, LLC | $75.562 | 16.215 | 0,13% | Hisse senetleri |
| LPL Financial LLC | $75.471 | 40.795 | 0,13% | Hisse senetleri |
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Voyageurs I Parallel, L.P., Versant Voyageurs I GP, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I GP Company, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC ×7 başvurular | 08 Ağustos 2024 | · | İlk başvuru | · | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×2 başvurular | 13 Mayıs 2024 | · | İlk başvuru | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah ×2 başvurular | 09 Mayıs 2024 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 22 içeriden öğrenenler · 10 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Mark A. Velleca | PRESIDENT & CEO | 21 Ocak 2026 A | 121.522 | 0 | 0 | $0 |
| David M. Epstein | Officer Title: President and Chief Executive Officer | 27 Haziran 2023 S | 671.423 | 0 | 0 | $0 |
| Fang Ni | Officer Title: Chief Business Officer and Chief Financial Officer | 14 Şubat 2024 A | 125.389 | 0 | 0 | $0 |
| Thomas Leggett | Chief Financial Officer | 17 Şubat 2021 A | 0 | 0 | 0 | $0 |
| Brent Hatzis-Schoch | Officer Title: Chief Operating Officer and General Counsel | 21 Ocak 2026 A | 83.400 | 0 | 0 | $0 |
| Erika Jones | Officer Title: Senior Vice President, Finance and Corporate Controller | 21 Ocak 2026 A | 85.150 | 0 | 0 | $0 |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | 21 Ocak 2026 A | 170.192 | 0 | 0 | $0 |
| Sergey Yurasov | CHIEF MEDICAL OFFICER | 21 Ocak 2026 A | 75.000 | 0 | 0 | $0 |
| Christopher D. Roberts | Chief Scientific Officer | 05 Nisan 2021 M | 3.200 | 0 | 0 | $0 |
| Rachel Humphrey | Chief Medical Officer | 17 Şubat 2021 A | 10.000 | 0 | 0 | $0 |
| Prakash Raman | Yönetim kurulu üyesi | 18 Eylül 2026 A | 51.840 | 0 | 0 | $0 |
| Ali Behbahani | Yönetim kurulu üyesi | 18 Eylül 2026 A | 110.236 | 0 | 0 | $0 |
| Shannon Campbell | Yönetim kurulu üyesi | 26 Haziran 2026 A | 8.865 | 0 | 0 | $0 |
| Samarth Kulkarni | Yönetim kurulu üyesi | 26 Haziran 2026 A | · | 0 | 0 | $0 |
| Garry E Menzel | Yönetim kurulu üyesi | 26 Haziran 2026 A | 51.825 | 0 | 0 | $0 |
| Kapil Dhingra | Yönetim kurulu üyesi | 26 Haziran 2026 A | · | 0 | 0 | $0 |
| Wendy L Dixon | Yönetim kurulu üyesi | 15 Mart 2024 A | 38.054 | 0 | 0 | $0 |
| Alexander Mayweg | Yönetim kurulu üyesi | 16 Mayıs 2023 A | · | 0 | 0 | $0 |
| Rajeev Shah | Yönetim kurulu üyesi | 16 Mayıs 2023 A | 0 | 0 | 0 | $0 |
| Bradley J Bolzon PhD | Yönetim kurulu üyesi | 18 Haziran 2021 A | 21.851 | 0 | 0 | $0 |
| Robert Alexander Ingram | · | 16 Aralık 2022 A | 42.854 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | · | 03 Şubat 2020 C | 568.185 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 16 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 158.433 SH | 11 Eylül 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 41.055 SH | 19 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,01% | 369.985 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 3.996 SH | 01 Ekim 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 9.610 SH | 01 Ekim 2026 | Günlük |
| DFSV · Dimensional ETF Trust | 0,00% | 210.208 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.187.063 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,00% | 22.531 NS | 31 Temmuz 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 31.143 SH | 30 Eylül 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,00% | 62.435 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 35.761 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 511.250 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.556.251 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 272.839 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 462.815 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 477.103 SH | 11 Eylül 2026 | Günlük |
BDTX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 14 analist
AL
Medyan hedef
$10.00
+429,1%
5 35,7%
Güçlü Al
7 50,0%
Al
2 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
7 analist · 2026-09-28Ortalama hedef $10.00 +429,1%
← Tüm hedeflerin altında
Mevcut fiyat $1.89
Düşük$8.00
Ortalama$10.00
Yüksek$14.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| OKUR | · | -0.7 | · | -1733.7% | -88.6% | · |
| ANIX | $136M | -12.1 | 0.00% | · | -62.2% | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026